Connor, Clark & Lunn Investment Management Ltd. Enovis Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $21.1 Billion
- Q1 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Enovis Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 89,970 shares of ENOV stock, worth $2.76 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
89,970
Previous 93,524
3.8%
Holding current value
$2.76 Million
Previous $4.11 Million
16.31%
% of portfolio
0.02%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding ENOV
# of Institutions
320Shares Held
63.9MCall Options Held
1.67MPut Options Held
473K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.21MShares$190 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$187 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$167 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO3.52MShares$108 Million0.09% of portfolio
-
Davenport & CO LLC3.07MShares$94.2 Million0.72% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $1.66B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...